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Summary
Objectives: To describe and identify factors, in clinical practice, that might be useful increasing the index of suspicion for diffuse idiopathic
skeletal hyperostosis (DISH), at a relatively young age.
Design: A group of 18 patients with DISH (12.8) who were diagnosed before the age of 50 years (group A) was compare with a group of 20
patients of similar age with osteoarthritis (group B), and 24 patients with DISH diagnosed after the age of 60 years (group C). Data collection
included demographic characteristics, body region of main complaint evidence for enthesopathies or tendonitis, length of follow-up, body mass
index (BMI), serum lipid proﬁle, family history of diabetes mellitus (DM), and hypertension (HTS). The presence of concomitant diseases and
use of medications was recorded at presentation and during the follow-up period.
Results: Patients in group A compared with group B, had statistically signiﬁcant more pain in the lumbar and thoracic spine (P¼ 0.001 and
0.016, respectively), tendonitis/enthesopathies (P¼ 0.004), obesity (BMI 30, P¼ 0.014), and ﬁrst degree relative with HTS and DM
(P¼ 0.015 and 0.05, respectively). By the end of the follow-up, signiﬁcantly more patients in group A were affected by DM compared with
group B (P¼ 0.007).
Conclusions: Individuals in the ﬁfth decade of life are likely to be affected by DISH if they are obese, have a ﬁrst degree relative with either
HTS or DM, complain of lumbar or thoracic spinal pain, and are affected by enthesopathies or tendonitis. The likelihood of relatively young
patients with 3 clinical parameters to be affected with DISH, was six times higher than age and sex matched controls (P¼ 0.004).
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Diffuse idiopathic skeletal hyperostosis (DISH) is a condition
characterized by calciﬁcation and ossiﬁcation of soft tis-
sues, mainly ligaments and enthesis. Recognition that the
condition is not limited to the spine, and also involves pe-
ripheral joints, led to the widely accepted term DISH1,2. De-
spite some similarities to osteoarthritis (OA), or its
coexistence with OA, it has some features that allow it to
be distinguished as a separate entity3.
The reported prevalence of DISH varies according the
age, ethnic origin, geographic location, and the clinical set-
ting (i.e., hospital-based vs population based). The preva-
lence increases with age and has seldom been reported
in individuals younger than 50 years of age.
The etiology of DISH is unknown. However, several met-
abolic, genetic, and constitutional factors were reported to
be associated with this condition. These include: obesity,
a high waist circumference ratio, hypertension (HTS), dia-
betes mellitus (DM), hyperinsulinemia, dyslipidemia, ele-
vated growth hormone levels, elevated insulin like growthaDepartment of Epidemiology and Public Health, Carmel Medical
Center, Haifa, Israel.
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825factor-1, hyperuricemia, use of retinoids and genetic fac-
tors4e8. A recent study showed that patients with DISH
are more often affected by metabolic syndrome and have
an increased risk for cardiovascular morbidity9.
At present, the diagnosis of DISH is based on character-
istic ﬁnding in radiographs of the thoracic spine, which are
seldom requested. Due to the clinical and metabolic impli-
cations of such a diagnosis, and for research purposes, di-
agnosis at an earlier age may be beneﬁcial. We tried
therefore, to identify factors, in clinical practice, that may
be useful in increasing the index of suspicion for this disor-
der, at a relatively young age. To the best of our knowledge,
no previous studies have characterized this subgroup of pa-
tients with DISH.Material and methods
From our cohort of 140 patients with DISH, we identiﬁed 18 patients
(12.8%) who were diagnosed before the age of 50 (group A). The median
age at diagnosis for the reminder of the cohort (122 patients) was 63.5 years
(range 52e85). Group A was compared with 20 patients of similar age with
OA (group B), and 24 patients with DISH diagnosed after the age of 60 years
(group C). All the patients with DISH met the Resnick classiﬁcation criteria10,
and all OA patients did not have radiological ﬁndings suggestive of DISH.
Data collection included demographic characteristics, body region of main
complaint (i.e., upper or lower limbs, cervical, thoracic, or lumbar spine,
chest, hips and shoulders girdle), clinical or radiographic evidence for enthe-
sopathies or tendonitis, length of follow-up, body mass index (BMI), serum
lipid proﬁle, family history of DM, HTS, and gout. The presence of ischemic
heart disease (IHD), cerebral vascular events (CVE), DM, and HTS, were
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pressure lowering agents (BPLA), anti diabetic agents (ADA), lipid lowering
agents (LLA), aspirin or other antiplatelet medications, allopurinol, and anti
anginal medications (AAM) were also recorded at presentation and during
the follow-up period. Data was collected from the patients’ medical records.
Whenever necessary, missing data were completed by telephone interview.
The local Helsinki committee approved the study.
Data analysis was performed using the SPSS statistical package (SPSS,
Chicago,IL). The relationships between two study groups (group A vs group
B, group A vs group C) and other categorical clinical and laboratory param-
eters were examined using the Chi-square test or ﬁsher’s exact test for small
groups.
t test or Mann-Whitney test were used to compare continuous variables
between two independent study groups.Results
Gender distribution was similar in all groups. The median
age at diagnosis for groups A, B, and C was 46, 51 and 70
years, respectively, and the median follow-up was 6, 6, and
3.5 years, respectively. Patients in group A compared to
group B, had more statistically signiﬁcant pain in the lumbar
and thoracic spine (P¼ 0.001 and 0.016, respectively), they
were signiﬁcantly more often affected by tendonitis and/or
enthesopathies (P¼ 0.004), and were signiﬁcantly more
likely to be obese (BMI 30, P¼ 0.014). They were also
more likely to have a ﬁrst degree relative with HTS and
DM (P¼ 0.015 and 0.05, respectively) (Table I). The differ-
ence in family history of HTS and DM was maintained even
when compared to group C (P¼ 0.031 and 0.009, respec-
tively). No other signiﬁcant differences, in favor of group
C, were noted. The prevalence of IHD, CVE, DM and
HTS did not differ between the groups at the time of diagno-
sis. These ﬁndings did not change at the end of the follow-
up except for the prevalence of patients affected with DM
which was signiﬁcantly higher in group A compared to
group B (P¼ 0.007). No signiﬁcant differences were ob-
served in the serum levels of total cholesterol, high density
lipoproteins (HDL), low density lipoproteins (LDL), triglycer-
ides (TG), and in the pattern of medications use at the time
of the diagnosis, except for more use of aspirin and BPLA in
group C vs group A. By the end of the follow-up a borderline
signiﬁcance was observed for use of ADA in group A vs
group B (Table II). Sixty seven percent of patients in group
A had at least three of the signiﬁcant parameters (thoracicTable
Group A e patients with DISH diagnosed at, or before the fifth decade of li
DISH. BMI e body mass index; DM e dia
Demographic a
Group A, N¼ 18 (%) Group B, N
Female 7 (38.9) 4 (2
Age at diagnosis (median) 46 (38e50) 51 (4
Years follow-up (median) 6 (1e14) 6 (1
Main area of complain:
Shoulder girdle 6 (33) 4 (2
Upper limbs 9 (50) 9 (4
Hip girdle 2 (11) 1 (5
Lower limbs 6 (33) 9 (4
Cervical spine 6 (33) 3 (1
Thoracic spine 7 (39) 1 (5
Lumbar spine 8 (44) 0
Chest 1 (6) 0
General pain 2 (11) 4 (2
Tendonitis/enthesopathy 8 (44) 1 (5
BMI Kg/m2 (mean) 34.2 30.6
BMI 30 kg/m2 15 (83) 9 (4
First degree relatives with DM 12 (67) 7 (3
First degree relatives with HTS 11 (61.1) 5 (2spine pain, lumbar spine pain, obesity, and family history
of HTS or DM), compared to only 10% in group B. Patients
in group A with 3 of these parameters were six times more
likely to be affected by DISH when compared to patients in
group B (85% vs 14% P¼ 0.004).
Admissions to hospital were similar between the groups.
A higher rate of admissions for cardiovascular diseases
(myocardial infarction, unstable angina pectoris, stroke or
transient ischemic attack) was observed for group C.Discussion
This study demonstrated that patients with DISH, diag-
nosed at a relatively young age, were signiﬁcantly more of-
ten affected by pain in the thoracic spine, lumbar spine
tendonitis and/or enthesopathies compared to patients
with similar age and gender distribution not affected by
DISH. These patients also had a signiﬁcantly higher preva-
lence of obesity, ﬁrst degree relatives with DM or HTS, and
were more likely to develop DM during follow-up. These
patients did not differ signiﬁcantly in most aspects from
patients with DISH diagnosed at an older age, except in
the case of a family history of DM and HTS.
The prevalence of DISH increases with age, but is
extremely variable according to the population studied,
and can be as high as 26% in females and 35% in males
of a hospital population11. An autopsy study reported that
in a series of 75 spines studied at autopsy 28% had
DISH12. Only a few studies reported the prevalence in
patients before 50 years of age, and some recent studies
did not look into this group at all13. However, the reported
prevalence in the ﬁfth decade of life was extremely low
ranging from 0.3% to 0.2% in males and females, respec-
tively in the Finish population to none in the female Italian
population14,15. It was estimated that a period of at least
10 years is needed for the pathologic process to evolve
completely suggesting, that the pathologic process starts
in the fourth decade of life16. Therefore, identifying DISH
at a relatively early age poses a diagnostic challenge. The
relatively high prevalence of patients with DISH in the pres-
ent study can be ascribed to the population of patients
referred to a rheumatology clinic, and probably to theI
fe; group B e patients without DISH; group C e elderly patients with
betes mellitus; HTS e hypertension
nd clinical characteristics of the study groups
¼ 20 (%) P, A vs B Group C, N¼ 24 (%) P, A vs C
0) NS 12 (50) NS
4e55) NS 70 (60e85) <0.0001
e23) NS 3.5 (2e9) NS
0) NS 10 (42) NS
5) NS 10 (42) NS
) NS 1 (4) NS
5) NS 13 (54) 0.17
5) NS 7 (29) NS
) 0.016 7 (29) NS
0.001 5 (21) 0.1
NS 2 (8) NS
0) NS 2 (8) NS
) 0.004 6 (25) NS
0.083 32.8 NS
5) 0.014 15 (63) 0.14
5) 0.05 6 (26) 0.009
5) 0.015 7 (30) 0.031
Table II
Group A e patients with DISH diagnosed at, or before the fifth decade of life; group B e patients without DISH; group C e elderly patients with
DISH;. ADA e anti diabetic agents; BPLA e blood pressure lowering agents; AAM e anti anginal medications; LLA e lipid lowering agents;
IHD e ischemic heart disease; CVE e cerebral vascular events; DM e diabetes mellitus; HTS e hypertension
Concomitant medications and comorbidities
Group A, N¼ 18 (%) Group B, N¼ 20 (%) P, A vs B Group C, N¼ 24 (%) P, A vs C
Medications at diagnosis
ADA 4 (22) 1 (5) 0.17 8 (33) NS
BPLA 5 (28) 2 (10) NS 18 (75) 0.025
AAM 1 (5.6) 0 NS 4 (17) NS
Aspirin 3 (17) 1 (5) NS 11 (46) 0.057
LLA 4 (22) 1 (5) 0.17 8 (33) NS
Medications during follow-up
ADA 7 (39) 2 (10) 0.058 9 (38) NS
BPLA 10 (56) 7 (35) NS 19 (79) NS
AAM 3 (17) 0 NS 3 (13) NS
Aspirin 9 (59) 6 (30) NS 18 (75) NS
LLA 12 (67) 8 (40) NS 16 (67) NS
Diseases at diagnosis
IHD 1 (5.6) 0 NS 1 (4.2) NS
CVE 2 (11) 0 NS 3 (12.5) NS
DM 5 (28) 1 (5) 0.08 9 (38) NS
HTS 7 (39) 6 (30) NS 18 (75) 0.018
Diseases by the end of F/U
IHD 3 (17) 2 (10) NS 4 (17) NS
CVE 2 (11) 0 NS 6 (25) NS
DM 9 (50) 2 (10) 0.007 11 (46) NS
HTS 11 (61) 7 (35) 0.1 20 (83) 0.1
Hospital admissions during F/U 7 (39) 9 (45) NS 13 (54) NS
827Osteoarthritis and Cartilage Vol. 17, No. 6enhanced awareness of the rheumatologists in this clinic.
Of particular interest is the fact that patients with DISH in
the ﬁfth decade of their life did not differ, in most parame-
ters, from elderly patients with DISH.
The level of pain and disability is signiﬁcantly higher when
compared with healthy subjects, but is not different from
that of patients with spondylitis. Complaints of pain refer-
able to the thoracic spine are common and are accompa-
nied by a reduced chest expansion. A study that
compared elderly patients with DISH with age and sex
matched individuals with spondylosis showed similar preva-
lence of thoracic spine pain between the groups, higher
prevalence of pain in the upper limbs in the DISH group
and more lumbar pain in the spondylosis group17. Thoracic
and lumbar spine pain as the presenting complaint was sig-
niﬁcantly more prevalent in patients with DISH, and could
represent the initial clue for this disease.
Peripheral enthesopathies are a common ﬁnding in DISH
and were considered to be of diagnostic value. Further-
more, they might explain some of the distinctive manifesta-
tions of the condition3. The association of DISH with excess
body weight is well known since the early descriptions by
Forestier and was reiterated recently17,18. The younger
age group was no exception, as was shown by the signiﬁ-
cant prevalence of obesity among patients with DISH com-
pared with non-DISH patients.
The genetic basis for DISH has not been elucidated. A
very high prevalence of DISH, starting at a relatively young
age, was found among Pima Indians. Although this commu-
nity had also a higher prevalence of HLA B27, no associa-
tion of DISH with HLA B27 was found19. There are some
descriptions of familial clustering, mainly in young sib-
lings20. Collagen 6A1 gene has been suggested as a candi-
date gene for DISH and ossiﬁcation of the posterior
longitudinal ligament in Japanese patients but not in other
populations21. In the present study, the prevalence of ﬁrstdegree relatives with either DM or HTS in the younger
patients with DISH was signiﬁcantly higher than the non-
DISH patients. Surprisingly, this was also true compared
to the elder group with DISH, and in particular for ﬁrst
degree relatives with DM. This ﬁnding might suggest that
the genetic impact is higher in the younger age group
than with elderly patients with DISH. Although the preva-
lence of DM did not differ between groups at presentation,
by the end of the follow-up signiﬁcantly more patients in
the younger age group with DISH were affected by DM
when compare with the non-DISH group.
Several constitutional and metabolic abnormalities have
been reported to be associated with DISH including obesity,
a high waist circumference HTS, DM, hyperinsulinemia,
dyslipidemia, and hyperuricemia4,5,7,8. The association of
DM and/or hyperinsulinemia with DISH, has been recently
questioned, and stressed the need for further studies to elu-
cidate this relationship17,22. However, at least in our sub-
group of relatively young patients with DISH, a family
history of DM on one hand, and the development of DM
in the following years, suggests that DM might play a role
either directly or indirectly, through yet unknown mediators,
in the pathogenesis of this condition. In the present study,
serum lipid levels did differ between the groups and reiter-
ate our previous ﬁndings9. The rates of hospital admissions
for cardiovascular events during the follow-up, was signiﬁ-
cantly higher in elderly patients with DISH and therefore
reﬂect the difference in age rather than the difference in
the diseases.
This study demonstrated that patients with a relatively
young onset age of DISH have similar characteristics to
elder patients with DISH. Several parameters differ signiﬁ-
cantly from patients with OA of similar age and sex. These
basic clinical parameters have a highly predictive value in
diagnosing these patients. In order to simulate a real life
clinical setting, we deliberately omitted enthesopathies
828 R. Mader and I. Lavi: Early onset DISHfrom the analysis because they often rely on imaging. The
metabolic abnormalities associated with DISH bear a signif-
icant risk for the development of metabolic syndrome and
cardiovascular disease9. The diagnosis of DISH in relatively
young individuals has practical implications for preventive
measures aiming to reduce the risk of such complications23.
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